A dual-incretin medication that acts on two pathways, GLP-1 and GIP, in a once-daily tablet instead of a weekly shot
The drugs also warn about side effects like pancreatitis, diabetic retinopathy, low blood sugar, kidney problems, allergic reactions and sudden gallbladder disease
As a peptide medication, tirzepatide requires careful storage to maintain its therapeutic effectiveness
De gepoolde resultaten bevestigden gemiddeld 14,33% gewichtsverlies over de volledige studiegroep (inclusief lagere doseringen), met ook significante verbeteringen in BMI, tailleomtrek en nuchtere bloedsuikerwaarden
Diets, medications, and exercise programs failed repeatedly
Dehydration and Electrolyte Imbalance GLP-1 medications can cause nausea, vomiting, and diarrhea, particularly during dose escalation